Shots:
The US FDA has approved ProVee System for the treatment of benign prostatic hyperplasia (BPH)
Approval was backed by the ProVIDE study assessing ProVee in men, which met its 1 & 2EPs, showing significant & durable symptom relief as well as improved urinary flow through 12mos. compared to sham, with preserved sexual function &…
